Gene: DBF4
Official Full Name: DBF4-CDC7 kinase regulatory subunitprovided by HGNC
Gene Summary: Predicted to enable protein serine/threonine kinase activator activity. Predicted to be involved in positive regulation of nuclear cell cycle DNA replication and regulation of cell cycle phase transition. Located in nuclear body. [provided by Alliance of Genome Resources, Jul 2025]
| Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
|---|---|---|---|---|---|---|
| KOA11273 | DBF4 Knockout cell line (AC16) | Human | DBF4 | 1:3-1:4 | negative | Online Inquiry |
| KOA26719 | DBF4 Knockout cell line (BEAS-2B) | Human | DBF4 | 1:3~1:4 | negative | Online Inquiry |
| KOA42156 | DBF4 Knockout cell line (U-2932) | Human | DBF4 | 1:2-1:4 | negative | Online Inquiry |
| KOA57535 | DBF4 Knockout cell line (TPC-1) | Human | DBF4 | 1:5-1:8 | negative | Online Inquiry |
| KOA72963 | DBF4 Knockout cell line (NCM460) | Human | DBF4 | 1:2~1:3 | negative | Online Inquiry |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.